HypervirulentClostridium difficileStrains in Hospitalized Patients, Canada1
Open Access
- 1 April 2010
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (4) , 678-681
- https://doi.org/10.3201/eid1604.091152
Abstract
To determine the incidence rate of infections with North American pulsed-field types 7 and 8 (NAP7/NAP8) strains of Clostrodium difficile, ribotype 078, and toxinotype V strains, we examined data collected for the Canadian Nosocomial Infections Surveillance Program (CNISP) CDI surveillance project during 2004–2008. Incidence of human infections increased from 0.5% in 2004/2005 to 1.6% in 2008.Keywords
This publication has 13 references indexed in Scilit:
- Emergence ofClostridium difficileInfection Due to a New Hypervirulent Strain, Polymerase Chain Reaction Ribotype 078Clinical Infectious Diseases, 2008
- Toxinotype VClostridium difficilein Humans and Food AnimalsEmerging Infectious Diseases, 2008
- Clostridium difficile Toxinotype V, Ribotype 078, in Animals and HumansJournal of Clinical Microbiology, 2008
- Clostridium difficile PCR Ribotype 078: an Emerging Strain in Humans and in Pigs?Journal of Clinical Microbiology, 2008
- Prevalence of PCR Ribotypes among Clostridium difficile Isolates from Pigs, Calves, and Other SpeciesJournal of Clinical Microbiology, 2007
- Molecular Analysis of Clostridium difficile PCR Ribotype 027 Isolates from Eastern and Western CanadaJournal of Clinical Microbiology, 2006
- A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and MortalityNew England Journal of Medicine, 2005
- An Epidemic, Toxin Gene–Variant Strain ofClostridium difficileNew England Journal of Medicine, 2005
- Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and EuropeThe Lancet, 2005
- gyrA and gyrB Mutations Are Implicated in Cross-Resistance to Ciprofloxacin and Moxifloxacin in Clostridium difficileAntimicrobial Agents and Chemotherapy, 2002